Charles Schwab’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-752
| Closed | -$2.26K | – | 3542 |
|
|
2023
Q3 | $2.26K | Hold |
752
| – | – | ﹤0.01% | 3573 |
|
|
2023
Q2 | $23.3K | Hold |
752
| – | – | ﹤0.01% | 3540 |
|
|
2023
Q1 | $37.2K | Hold |
752
| – | – | ﹤0.01% | 3400 |
|
|
2022
Q4 | $18.5K | Hold |
752
| – | – | ﹤0.01% | 3509 |
|
|
2022
Q3 | $50K | Hold |
752
| – | – | ﹤0.01% | 3327 |
|
|
2022
Q2 | $32K | Hold |
752
| – | – | ﹤0.01% | 3455 |
|
|
2022
Q1 | $38K | Hold |
752
| – | – | ﹤0.01% | 3555 |
|
|
2021
Q4 | $46K | Hold |
752
| – | – | ﹤0.01% | 3521 |
|
|
2021
Q3 | $38K | Hold |
752
| – | – | ﹤0.01% | 3475 |
|
|
2021
Q2 | $43K | Sell |
752
-4,456
| -86% | -$255K | ﹤0.01% | 3389 |
|
|
2021
Q1 | $300K | Buy |
5,208
+859
| +20% | +$49.5K | ﹤0.01% | 3242 |
|
|
2020
Q4 | $296K | Sell |
4,349
-357
| -8% | -$24.3K | ﹤0.01% | 3165 |
|
|
2020
Q3 | $1.2M | Buy |
4,706
+121
| +3% | +$30.7K | ﹤0.01% | 2635 |
|
|
2020
Q2 | $772K | Buy |
4,585
+3,833
| +510% | +$645K | ﹤0.01% | 2699 |
|
|
2020
Q1 | $53K | Hold |
752
| – | – | ﹤0.01% | 3151 |
|
|
2019
Q4 | $49K | Hold |
752
| – | – | ﹤0.01% | 3121 |
|
|
2019
Q3 | $45K | Hold |
752
| – | – | ﹤0.01% | 3123 |
|
|
2019
Q2 | $45K | Hold |
752
| – | – | ﹤0.01% | 3155 |
|
|
2019
Q1 | $49K | Buy |
+752
| New | +$49K | ﹤0.01% | 3131 |
|